Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discove.ry

AZoNetwork launches Azthena, your personal scientific assistant

Leading scientific publisher introduces an AI assistant trained on 23 years of scientific content.

November 2, 2023

BridgeBio inks $250M PIPE two months after PhIII heart pill win, hints at more financing

BridgeBio will gain about $250 million via a private investment as the biotech nears an approval submission for its heart pill, two months after initially

September 26, 2023

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.